OTCMKTS:MSLP

MusclePharm (MSLP) Stock Price, News & Analysis

$0.0002
0.00 (0.00%)
(As of 12/16/2022)
Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.0002
$0.0002
Volume
1,000 shs
Average Volume
26,442 shs
Market Capitalization
$6,678.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MSLP stock logo

About MusclePharm Stock (OTCMKTS:MSLP)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

MSLP Stock Price History

MSLP Stock News Headlines

The 5 best muscle rubs of 2024
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
What Are the Best Foods for Building Muscle?
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
How To Build Muscle, According To Experts
Can You Gain Muscle While Losing Weight?
Dae Hwa Pharm Co Ltd (067080)
Why MusclePharm (MSLP) Stock Is Up Today
MusclePharm Announces the Launch of FitMiss Energy
MusclePharm Files For Uplisting IPO To Nasdaq
MusclePharm Announces First Quarter 2022...
MusclePharm releases preliminary Q421 results
See More Headlines
Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2015
Today
5/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MSLP
Fax
N/A
Employees
27
Year Founded
2008

Profitability

Net Income
$-12,870,000.00
Pretax Margin
-38.52%

Debt

Sales & Book Value

Annual Sales
$50.04 million
Book Value
($0.94) per share

Miscellaneous

Free Float
13,121,000
Market Cap
$7,000.00
Optionable
Not Optionable
Beta
-0.07

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Ryan Charles Drexler (Age 51)
    Exec. Chairman & CEO
    Comp: $1.64M
  • John Mills Mills
    Sr. Managing Director
  • Mr. Gary Charles Shirshac (Age 60)
    Interim Chief Financial Officer
  • Mr. Eric Chin (Age 42)
    Chief Accounting Officer & Director
  • Dr. Roscoe M. Moore Jr. (Age 77)
    DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board
  • Mr. Mark E. Groussman (Age 49)
    Consultant

MSLP Stock Analysis - Frequently Asked Questions

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) released its quarterly earnings data on Monday, August, 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The company earned $50.48 million during the quarter, compared to the consensus estimate of $55 million.

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY).

How do I buy shares of MusclePharm?

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MSLP) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners